Tumor and glioma tissue

Tumor and glioma tissue refers to the pathological mass of cells resulting from the neoplastic transformation of glial cells within the central nervous system [1]. Gliomas are the most common primary brain tumors and are categorized into various grades and types, such as astrocytomas, oligodendrogliomas, and glioblastomas, based on their histological and molecular features [2, 3]. While the tissue itself is the site of therapeutic intervention, it is not a single molecular target; rather, it represents a complex microenvironment containing multiple potential targets like IDH1, EGFR, and VEGF [3]. Treatment of glioma tissue is particularly challenging due to the blood-brain barrier, which limits the delivery of many pharmacological agents, and the high degree of intratumoral heterogeneity that often leads to treatment resistance and recurrence [2, 4]. Current therapeutic approaches typically involve a combination of surgical resection, radiotherapy, and chemotherapy tailored to the specific molecular profile of the tumor tissue [3, 4].

Other names

Glioma tissueMalignant gliomaBrain tumor tissueGlial tumorNeoplastic brain tissue

Not applicable. This entry describes a tissue type and disease state rather than a specific molecular target. Drugs acting on this tissue typically target specific intracellular enzymes, receptors, or DNA within the tumor cells [1, 3].